DuPont Nutrition & Biosciences announces research collaboration with Rutgers University

Next-generation microbiome science solutions

Photo - Dupont

DuPont Nutrition & Biosciences (DuPont) announced a research collaboration in microbiome science with the Center for Advanced Biotechnology and Medicine (CABM) at Rutgers University in New Jersey.

The two-year research partnership will focus on improving the benefit or risk ratio of chemotherapy by decreasing gut inflammation caused by chemotherapy to improve response rates through modulation of the microbiome potentially. Recent studies demonstrate that microbiome plays an important role in gut inflammation and that oral intake of oncology drugs can induce enterocolitis. As such, the administration of beneficial microbes may improve overall patient care and comfort while undergoing cancer treatment.

“We are privileged to be working with Dr Martin J Blaser, Dr Fang Liu and their team at Rutgers on a project targeted at improving patient care for those undergoing chemotherapy, and to combine world-class science from Dr Blaser and his team with our broad portfolio of microbes to further advance the understanding of the intake of beneficial microbes on human health,” said Sébastien Guéry, Human Microbiome Venture leader, DuPont Nutrition & Biosciences.

DuPont Human Microbiome Venture (HMV)

The DuPont Human Microbiome Venture (HMV) was launched in 2017 to spearhead the development of next-generation microbiome solutions for improved health and wellness. Staying at the forefront of biotechnology innovation, HMV is designed to accelerate product development to complement its existing portfolio and build on DuPont’s strong expertise in prebiotics, microbes, proteins, and enzymes use for human health.

“We are delighted to develop further our relationship with DuPont for the benefit of human health,” said Martin J Blaser, director of the Center for Advanced Biotechnology and Medicine. “The interaction of the microbiome with cancer is an important frontier, with important leads already. Our project is aimed to discover new ways to improve cancer therapies.”

The CABM mission is to make fundamental discoveries and develop new technologies that can be translated to improve human health.

DuPont Nutrition & Biosciences applies expert science to advance healthy and sustainable solutions for the food, beverage, dietary supplement, and pharmaceutical industries.


Please enter your comment!
Please enter your name here